Annual CFI
-$14.00 K
NaN%
December 31, 2023
Summary
- As of February 10, 2025, ONTX annual cash flow from investing activities is -$14.00 thousand
- During the last 3 years, ONTX annual CFI has risen by +$1000.00 (+6.67%).
Performance
ONTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
N/A
March 31, 2024
Summary
- ONTX quarterly cash flow from investing activities is not available.
Performance
ONTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
March 31, 2024
Summary
- ONTX TTM cash flow from investing activities is not available.
Performance
ONTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ONTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +6.7% | - | - |
| 5 y5 years | -100.0% | - | - |
ONTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | ||||
| 5 y | 5-year | at high | +292.9% | ||||
| alltime | all time | -100.0% | >+9999.0% |
Onconova Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$14.00 K(-6.7%) | $0.00(-100.0%) | -$14.00 K(0.0%) |
| Sep 2023 | - | -$14.00 K(<-9900.0%) | -$14.00 K(<-9900.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2020 | -$15.00 K(-72.7%) | $0.00(0.0%) | -$15.00 K(+7.1%) |
| Sep 2020 | - | $0.00(-100.0%) | -$14.00 K(-80.0%) |
| Jun 2020 | - | -$15.00 K(-1600.0%) | -$70.00 K(+27.3%) |
| Dec 2019 | -$55.00 K(<-9900.0%) | $1000.00(-101.8%) | -$55.00 K(-1.8%) |
| Sep 2019 | - | -$56.00 K(<-9900.0%) | -$56.00 K(<-9900.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2015 | - | $0.00(0.0%) | $14.99 M(0.0%) |
| Jun 2015 | - | $0.00(0.0%) | $14.99 M(-49.8%) |
| Mar 2015 | - | $0.00(-100.0%) | $29.84 M(-25.0%) |
| Dec 2014 | $39.77 M(-198.0%) | $14.99 M(>+9900.0%) | $39.77 M(+61.1%) |
| Sep 2014 | - | $0.00(-100.0%) | $24.68 M(-260.8%) |
| Jun 2014 | - | $14.85 M(+49.6%) | -$15.35 M(-49.5%) |
| Mar 2014 | - | $9.93 M(<-9900.0%) | -$30.39 M(-25.2%) |
| Dec 2013 | -$40.60 M(>+9900.0%) | -$94.00 K(-99.8%) | -$40.60 M(-0.1%) |
| Sep 2013 | - | -$40.03 M(>+9900.0%) | -$40.65 M(+5349.5%) |
| Jun 2013 | - | -$189.00 K(-33.5%) | -$746.00 K(+33.5%) |
| Mar 2013 | - | -$284.00 K(+91.9%) | -$559.00 K(+100.4%) |
| Dec 2012 | -$279.00 K(+15.8%) | -$148.00 K(+18.4%) | -$279.00 K(+113.0%) |
| Sep 2012 | - | -$125.00 K(+6150.0%) | -$131.00 K(+2083.3%) |
| Jun 2012 | - | -$2000.00(-50.0%) | -$6000.00(+50.0%) |
| Mar 2012 | - | -$4000.00 | -$4000.00 |
| Dec 2011 | -$241.00 K | - | - |
FAQ
- What is Onconova Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Onconova Therapeutics?
- What is the all time high quarterly CFI for Onconova Therapeutics?
- What is the all time high TTM CFI for Onconova Therapeutics?
What is Onconova Therapeutics annual cash flow from investing activities?
The current annual CFI of ONTX is -$14.00 K
What is the all time high annual CFI for Onconova Therapeutics?
Onconova Therapeutics all-time high annual cash flow from investing activities is $39.77 M
What is the all time high quarterly CFI for Onconova Therapeutics?
Onconova Therapeutics all-time high quarterly cash flow from investing activities is $14.99 M
What is the all time high TTM CFI for Onconova Therapeutics?
Onconova Therapeutics all-time high TTM cash flow from investing activities is $39.77 M